A Study on Injection Pain Caused by Subcutaneous Administration of Biologics in Patients with Bronchial Asthma

A Study on Injection Pain Caused by Subcutaneous Administration of Biologics in Patients with Bronchial Asthma - A Study on Injection Pain by Subcutaneous Administration of Biologics

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000057792

Enrollment

Registered

2025-05-07

Start date

2025-05-07

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

bronchial asthma, diabetes

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with bronchial asthma receiving biologic therapy and patients with diabetes receiving subcutaneous injections via auto-injectors

Exclusion criteria

Exclusion criteria: Patients for whom it is difficult to obtain a questionnaire from the individual due to severe dementia, mental illness, or other conditions. Patients currently using regular analgesics. Patients who have complained of pain prior to the initiation of biologic therapy. Other cases deemed unsuitable by the attending physician.

Design outcomes

Primary

Measure	Time frame
The relationship between the severity of injection pain from biologic therapies and the willingness to continue treatment	—

Secondary

Measure	Time frame
Effect of pressure or cooling on the reduction of injection-related pain. Association between injection pain from biologic therapies and various clinical parameters. Difference of injection pain between subcutaneous formulations used in diabetic and bronchial asthma patients.	—

Countries

Japan

Contacts

Public ContactYutaka Wakita

Saiseikai-Noe Hospital General Affairs Department

yutaka.wakita@noe.saiseikai.or.jp0669320401

Outcome results